A new method for early detection of Alzheimer's disease using blood samples
High-sensitivity Immunomagnetic System for "Liquid Biopsy" of Alzheimer's Disease
This study is working on a new, easy way to check for signs of Alzheimer's disease in blood samples, which could help doctors catch it earlier and more affordably, making it easier for more people to get tested.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11004151 on NIH RePORTER |
What this research studies
This research focuses on developing a high-sensitivity immunomagnetic system to detect biomarkers associated with Alzheimer's disease (AD) in blood samples. By measuring levels of amyloid-β peptides and tau proteins, the goal is to provide a non-invasive and cost-effective diagnostic tool that can be used at the point-of-care. This approach aims to overcome the limitations of current imaging techniques, making early detection and monitoring of AD more accessible to a larger population. The research addresses the challenge of low biomarker concentrations in blood and aims to improve diagnostic accuracy.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those in the early stages of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those without any risk factors for the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of Alzheimer's disease, allowing for timely interventions.
How similar studies have performed: Previous research has shown promise in using blood-based biomarkers for Alzheimer's detection, indicating that this approach has potential for success.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Mao, Hui — Emory University
- Study coordinator: Mao, Hui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.